“We have no greater friend, no greater partner, no greater ally than Australia,” declared Antony Blinken, America’s secretary of state, during a recent visit down under. Is that really true, and how is the threat from China reshaping America’s relationships in the Indo-Pacific? John Prideaux hosts with Charlotte Howard and Anton La Guardia. They’re joined by Eleanor Whitehead, The Economist’s Australia correspondent. Sign up for Economist Podcasts+ now and get 50% off your subscription with our limited time offer.You will not be charged until Economist Podcasts+ launches. If you’re already a subscriber to The Economist, you’ll have full access to all our shows as part of your subscription. For more information about Economist Podcasts+, including how to get access, please visit our FAQs page.The Economist Live is coming to New York and Washington, DC this October. Learn more about our live events. Hosted on Acast. See acast.com/privacy for more information.

Reporting from the ground, our Eastern Europe editor explores how the country is bracing for a new phase of war. In some ways, people have adapted, but equally the invasion has clearly taken a mental toll. Reflecting on the life of the Zulu chief turned politician Mangosuthu Buthelezi (11:51). And how to get out of jail (18:39).Sign up for Economist Podcasts+ now and get 50% off your subscription with our limited time offer. You will not be charged until Economist Podcasts+ launches.If you’re already a subscriber to The Economist, you’ll have full access to all our shows as part of your subscription.For more information about Economist Podcasts+, including how to get access, please visit our FAQs page. Hosted on Acast. See acast.com/privacy for more information.

One of the many aims of President Joe Biden’s signature legislation, the Inflation Reduction Act, is to cut the cost of drugs prescribed by Medicare, a government health insurance programme for Americans 65 and over. But the policy could have some side-effects for patients far beyond the US.Hosts: Tom Lee-Devlin and Mike Bird. Contributors: Shailesh Chitnis, The Economist’s global business correspondent; Tricia Neuman, a senior advisor to Mr Biden; and David Fredrickson of AstraZeneca.Sign up for Economist Podcasts+ now and get 50% off your subscription with our limited time offer: www.economist.com/podcastsplus-moneytalksYou will not be charged until Economist Podcasts+ launches. If you’re already a subscriber to The Economist, you’ll have full access to all our shows as part of your subscription. For more information about Economist Podcasts+, including how to get access, please visit our FAQs page. Hosted on Acast. See acast.com/privacy for more information.

It would not be the first time that a member of the government has gone missing, not even the first time this year. But what does this say about the leadership of the People’s Liberation Army? No one cares about Apple’s new iPhone, but the tech giant has more to worry about (09:24). And why an old-school motorbike is still driving new hype in India (16:00).Sign up for Economist Podcasts+ now and get 50% off your subscription with our limited time offer. You will not be charged until Economist Podcasts+ launches.Visit http://www.economist.com/podcastsplus-intelligence to join.If you’re already a subscriber to The Economist, you’ll have full access to all our shows as part of your subscription.For more information about Economist Podcasts+, including how to get access, please visit our FAQs page. Hosted on Acast. See acast.com/privacy for more information.

Discussions about artificial intelligence tend to focus on its risks, but there is also excitement on the horizon. AI tools, like the models beneath ChatGPT, are being increasingly used by scientists for everything from finding new drugs and materials to predicting the shapes of proteins. Self-driving lab robots could take things even further towards making new discoveries. As it gets ever more useful, could AI change the scientific process altogether?Jane Dyson, structural biologist at the Scripps Research Institute in La Jolla, California, explains why Google DeepMind’s AlphaFold tool is useful, but scientists should be aware of its limitations. This week, Google DeepMind released a new tool to unpick the link between genes and disease, as Pushmeet Kohli, head of the company’s “AI for Science” team, explains. Also, Kunal Patel, one of our producers, meets Erik Bjurström, a researcher at Chalmers University of Technology and Ross King, a professor of Machine Intelligence at Chalmers University of Technology and at the University of Cambridge. They explain why self-driving lab robots could make research more efficient. Alok Jha, The Economist’s science and technology editor hosts, with Abby Bertics, our science correspondent and Tom Standage, deputy editor. Sign up for Economist Podcasts+ now and get 50% off your subscription with our limited time offer: economist.com/podcastsplus. You will not be charged until Economist Podcasts+ launches.If you’re already a subscriber to The Economist, you’ll have full access to all our shows as part of your subscription.For more information about Economist Podcasts+, including how to get access, please visit our FAQs page. Hosted on Acast. See acast.com/privacy for more information.